863237-44-9

Upstream product

• 863237-59-6 1,5-Bis-benzyloxy-2-[3-(3-benzyloxy-phenyl)-3-bromo-propyl]-3-methoxymethoxy-benzene 
• 863237-42-7 3',4,6-tribenzyloxy-2-methoxymethyloxy-E-retrochalcone 
• 863237-43-8 1-(3'-benzyloxyphenyl)-3-(2''-methoxymethyloxy-4'',6''-dibenzyloxyphenyl)propan-1-ol 
• 863237-57-4 1-(3-benzyloxy-phenyl)-3-(2,4-bis-benzyloxy-6-methoxymethoxy-phenyl)-propan-1-one 
• 34068-01-4 1-[3-(phenylmethoxy)phenyl]ethan-1-one 
• 487-70-7 2,4,6-trihydroxybenzaldehyde 
• 100-39-0 benzyl bromide 
• 863237-41-6 4,6-dibenzyloxy-2-methoxymethyloxybenzaldehyde 
• 863237-56-3 2,4-bis-benzyloxy-6-hydroxy-benzaldehyde 

Downstream Products

• 863237-45-0 (1R,2R)-1-(3'-benzyloxyphenyl)-3-(2''-methoxymethyloxy-4'',6''-dibenzyloxyphenyl)propane-1,2-diol 
• 863237-46-1 (1R,2R)-1-(3'-benzyloxyphenyl)-3-(2''-hydroxy-4'',6''-dibenzyloxyphenyl)propane-1,2-diol 

Relevant academic research and scientific papers

Asymmetric total synthesis of B-ring modified (-)-epicatechin gallate analogues and their modulation of β-lactam resistance in Staphylococcus aureus

Two enantiomerically pure B-ring modified analogues of (-)-epicatechin gallate were synthesised and their modulation of β-lactam resistance using three strains of methicillin resistant Staphylococcus aureus (BB 568, EMRSA-15 and EMRSA-16) evaluated. Sub-i